BioAtla, Inc. — Form 8-K
Filed August 28, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
BioAtla, Inc. filed an 8-K on 2026-08-28 reporting Item 3.01 — Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing. The filing provides no specific details regarding which exchange issued the notice, the specific listing standards violated, remediation timeline, or transfer destination. The company's public market value is approximately $18.7M.
Why this rating
Delisting is existential threat to public company. No turnaround details disclosed. Massive relative to $18.7M market cap.
Extracted items
Tradability signal
SHORT
conviction 56/100 · expected -2.66% over 4 hrs
SHORT (drift): bad news keeps sliding after dissemination — our one persistent measured edge. Similar past filings (5 in this cell) moved +15.95% in the called direction over 4 hrs; shrunk for sample size that's a +2.66% edge. Caution: sub-$5 shorts can be hard to borrow — treat as avoid-longs if no locate.
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
at our read · backfill $1.75 | +10 min · backfill $1.37 ▼ 21.71% | +30 min · backfill $1.34 ▼ 23.43% | +1 hr · backfill $1.70 ▼ 2.86% | +4 hrs · backfill $1.77 ▲ 0.98% |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from August 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.